On June 1, 2021 VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, reported that Jeff Baxter, President and Chief Executive Officer, and David E. Anderson, Ph.D., Chief Scientific Officer, will participate in analyst-led fireside chats at the following upcoming investor conferences (Press release, VBI Vaccines, JUN 1, 2021, View Source [SID1234583322]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Virtual Healthcare Conference
Analyst discussion to be held with Kelechi Chikere, Ph.D.
Date: Thursday, June 3, 2021
Time: 1-1:25 PM ET
Webcast Link: View Source
Raymond James Human Health Innovation Conference
Analyst discussion to be held with Steven Seedhouse, Ph.D.
Date: Wednesday, June 23, 2021
Time: 12-12:30 PM ET
Webcast Link: View Source
Live webcasts of the presentations will also be available on the Investors page of VBI’s website at: View Source A replay of each webcast will be archived on the Company’s website following the presentation.